Search Results:  Human Immunodeficiency Virus  (3)

  • European Medicines Agency (EMA) approval of the dapivirine ring for HIV prevention for women in high HIV burden settings

    The European Medicines Agency announced today that its human medicines committee provided a positive benefit-risk opinion on the use of the Dapivirine Vaginal Ring (DPV-VR) for HIV prevention. WHO stresses that when providing HIV prevention for women it is always critical to provide these alongside other services including STI diagnosis and treatment, HIV testing and links to antiretroviral therapy for all women who test positive and a range of contraception options.

    Roles: Everyone: All Users

    Regions: Kenya

    Topics: Global Health, Global Women's Issues

  • #EndTB Webinar: From Policy to Practice: Rolling out new WHO guidelines on rapid diagnostics and drug-resistant TB treatment

    A special #EndTB Webinar organized by the World Health Organization (WHO) to provide key updates on recently released new WHO guidance on rapid diagnostics and drug-resistant TB treatment. The aim of the webinar is to facilitate better understanding of the guidance to enable its rapid uptake in countries by national programmes and other key stakeholders. This will translate to earlier access to quality diagnosis and treatment, and better outcomes for the millions affected by TB and drug-resistant TB.

    Roles: Everyone: All Users

    Regions: United Kingdom

    Topics: Global Health, Science, Technology, and Innovation

  • COVID-19: What people with HIV should know

    Roles: Everyone: All Users

    Regions: China

    Topics: Coronavirus (COVID-19), Global Health

Results 1 - 3 of 3

  • Regions









































































































































































































































  • Topics